Sujan Kumar Mondal

Title: Sujan Kumar Mondal: Innovator in Anticancer Research

Introduction

Sujan Kumar Mondal is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of cancer research through his innovative work on progesterone compounds. His research focuses on developing novel anti-tumor agents that can potentially revolutionize cancer treatment.

Latest Patents

Sujan Kumar Mondal holds a patent for "Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof." This invention relates to the development of cationic progesterone compounds as a novel anti-tumor agent. The patent outlines a method for preparing a series of progesterone derivatives, which exhibit highly selective anti-cancer activities across a wide range of cancer cells, regardless of their progesterone receptor status. The disclosed cationic progesterone compounds present a viable option for anti-cancer therapeutics.

Career Highlights

Sujan Kumar Mondal is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and therapeutic options. With 1 patent to his name, he continues to push the boundaries of scientific innovation.

Collaborations

Some of his notable coworkers include Sudhakar Jinka and Rajkumar Banerjee. Their collaborative efforts contribute to the advancement of research in the field of cancer therapeutics.

Conclusion

Sujan Kumar Mondal's innovative work in developing progesterone-based anti-cancer agents highlights the importance of research in finding effective treatments for cancer. His contributions to the field are paving the way for future advancements in cancer therapy.